Author:
Alqudah Mohammad A. Y.,Al-azzam Sayer,Alzoubi Karem,Alkhatatbeh Mohammad,Alawneh Khaldoon,Alazzeh Ola,Ababneh Bayan
Funder
Jordan University of Science and Technology
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Immunology
Reference28 articles.
1. Ajeganova S, Andersson ML, Frostegard J, Hafstrom I (2013) Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study. J Rheumatol 40:1958–1966
2. Aletaha D, Smolen JS (2002) Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. Obs Study J Rheumatol 29:1631–1638
3. Aletaha D, Kapral T, Smolen JS (2003) Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. Ann Rheum Dis 62:482–486
4. Bakker MF, Jacobs JW, Verstappen SM, BIjlsma JW (2007) Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility. Ann Rheum Dis 66(Suppl 3):iii56–60
5. Bianchi G, Caporali R, Todoerti M, Mattana P (2016) Methotrexate and rheumatoid arthritis: current evidence regarding subcutaneous versus oral routes of administration. Adv Ther 33:369–378
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献